227 related articles for article (PubMed ID: 32898162)
1. Identification of a homology-independent linchpin domain controlling mouse and bank vole prion protein conversion.
Burke CM; Mark KMK; Walsh DJ; Noble GP; Steele AD; Diack AB; Manson JC; Watts JC; Supattapone S
PLoS Pathog; 2020 Sep; 16(9):e1008875. PubMed ID: 32898162
[TBL] [Abstract][Full Text] [Related]
2. Cofactor and glycosylation preferences for in vitro prion conversion are predominantly determined by strain conformation.
Burke CM; Walsh DJ; Mark KMK; Deleault NR; Nishina KA; Agrimi U; Di Bari MA; Supattapone S
PLoS Pathog; 2020 Apr; 16(4):e1008495. PubMed ID: 32294141
[TBL] [Abstract][Full Text] [Related]
3. Assessment of the PrPc Amino-Terminal Domain in Prion Species Barriers.
Davenport KA; Henderson DM; Mathiason CK; Hoover EA
J Virol; 2016 Dec; 90(23):10752-10761. PubMed ID: 27654299
[TBL] [Abstract][Full Text] [Related]
4. Folding and misfolding of the prion protein in the secretory pathway.
Tatzelt J; Winklhofer KF
Amyloid; 2004 Sep; 11(3):162-72. PubMed ID: 15523918
[TBL] [Abstract][Full Text] [Related]
5. Prion propagation in mice expressing human and chimeric PrP transgenes implicates the interaction of cellular PrP with another protein.
Telling GC; Scott M; Mastrianni J; Gabizon R; Torchia M; Cohen FE; DeArmond SJ; Prusiner SB
Cell; 1995 Oct; 83(1):79-90. PubMed ID: 7553876
[TBL] [Abstract][Full Text] [Related]
6. Role of donor genotype in RT-QuIC seeding activity of chronic wasting disease prions using human and bank vole substrates.
Hwang S; Greenlee JJ; Nicholson EM
PLoS One; 2020; 15(1):e0227487. PubMed ID: 31910440
[TBL] [Abstract][Full Text] [Related]
7. Altered distribution, aggregation, and protease resistance of cellular prion protein following intracranial inoculation.
Ward A; Hollister JR; Choi YP; Race B; Williams K; Shoup DW; Moore RA; Priola SA
PLoS One; 2019; 14(7):e0219457. PubMed ID: 31291644
[TBL] [Abstract][Full Text] [Related]
8. A domain responsible for spontaneous conversion of bank vole prion protein.
Kobayashi A; Matsuura Y; Takeuchi A; Yamada M; Miyoshi I; Mohri S; Kitamoto T
Brain Pathol; 2019 Mar; 29(2):155-163. PubMed ID: 30051525
[TBL] [Abstract][Full Text] [Related]
9. PrPC Governs Susceptibility to Prion Strains in Bank Vole, While Other Host Factors Modulate Strain Features.
Espinosa JC; Nonno R; Di Bari M; Aguilar-Calvo P; Pirisinu L; Fernández-Borges N; Vanni I; Vaccari G; Marín-Moreno A; Frassanito P; Lorenzo P; Agrimi U; Torres JM
J Virol; 2016 Dec; 90(23):10660-10669. PubMed ID: 27654300
[TBL] [Abstract][Full Text] [Related]
10. A transmembrane form of the prion protein in neurodegenerative disease.
Hegde RS; Mastrianni JA; Scott MR; DeFea KA; Tremblay P; Torchia M; DeArmond SJ; Prusiner SB; Lingappa VR
Science; 1998 Feb; 279(5352):827-34. PubMed ID: 9452375
[TBL] [Abstract][Full Text] [Related]
11. Full restoration of specific infectivity and strain properties from pure mammalian prion protein.
Burke CM; Walsh DJ; Steele AD; Agrimi U; Di Bari MA; Watts JC; Supattapone S
PLoS Pathog; 2019 Mar; 15(3):e1007662. PubMed ID: 30908557
[TBL] [Abstract][Full Text] [Related]
12. The protease-sensitive N-terminal polybasic region of prion protein modulates its conversion to the pathogenic prion conformer.
Zhang X; Pan YH; Chen Y; Pan C; Ma J; Yuan C; Yu G; Ma J
J Biol Chem; 2021 Nov; 297(5):101344. PubMed ID: 34710372
[TBL] [Abstract][Full Text] [Related]
13. The N-terminal, polybasic region of PrP(C) dictates the efficiency of prion propagation by binding to PrP(Sc).
Turnbaugh JA; Unterberger U; Saá P; Massignan T; Fluharty BR; Bowman FP; Miller MB; Supattapone S; Biasini E; Harris DA
J Neurosci; 2012 Jun; 32(26):8817-30. PubMed ID: 22745483
[TBL] [Abstract][Full Text] [Related]
14. A receptor for infectious and cellular prion protein.
Martins VR
Braz J Med Biol Res; 1999 Jul; 32(7):853-9. PubMed ID: 10454744
[TBL] [Abstract][Full Text] [Related]
15. Sheep scrapie susceptibility-linked polymorphisms do not modulate the initial binding of cellular to disease-associated prion protein prior to conversion.
Rigter A; Bossers A
J Gen Virol; 2005 Sep; 86(Pt 9):2627-2634. PubMed ID: 16099922
[TBL] [Abstract][Full Text] [Related]
16. Prion protein transgenes and the neuropathology in prion diseases.
DeArmond SJ; Prusiner SB
Brain Pathol; 1995 Jan; 5(1):77-89. PubMed ID: 7767493
[TBL] [Abstract][Full Text] [Related]
17. Truncated PrP(c) in mammalian brain: interspecies variation and location in membrane rafts.
Laffont-Proust I; Hässig R; Haïk S; Simon S; Grassi J; Fonta C; Faucheux BA; Moya KL
Biol Chem; 2006 Mar; 387(3):297-300. PubMed ID: 16542151
[TBL] [Abstract][Full Text] [Related]
18. Oxidative and Inflammatory Events in Prion Diseases: Can They Be Therapeutic Targets?
Prasad KN; Bondy SC
Curr Aging Sci; 2019; 11(4):216-225. PubMed ID: 30636622
[TBL] [Abstract][Full Text] [Related]
19. Prions and prion diseases.
Pergami P; Poloni TE; Corato M; Camisa B; Ceroni M
Funct Neurol; 1999; 14(4):241-52. PubMed ID: 10713898
[No Abstract] [Full Text] [Related]
20. Non-genetic propagation of strain-specific properties of scrapie prion protein.
Bessen RA; Kocisko DA; Raymond GJ; Nandan S; Lansbury PT; Caughey B
Nature; 1995 Jun; 375(6533):698-700. PubMed ID: 7791905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]